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Chapter 8 
Comparison of Healthcare Systems Performance 
Irene Papanicolas and Jonathan Cylus 
 
 
Introduction 
 
Health systems, healthcare and health policy are different in every country. Each 
nation’s health system has been shaped by a number of influences including cultural 
norms, politics and history. Despite the diverse patient populations and structural 
differences which exist across health systems, most countries share common health 
system goals and face similar challenges. Most health systems aim to improve 
patient health, be responsive to patient needs and at the same time ensure financial 
sustainability (WHO, 2000). At the same time, most health systems also face 
common challenges, such as demographic change and escalating costs. 
International comparisons provide vast potential for within and cross country 
learning; by offering a way to explore different approaches countries take to address 
similar problems to achieve comparable objectives (Nolte et al., 2006). 
 
Health system performance can exert a major influence on national policymakers, 
but neither the bald presentation of league tables nor a detailed narrative of caveats 
is likely to guide them towards appropriate responses. The improvements 
themselves will take more work at the national level for policy-makers to understand 
characteristics and processes that contribute to relative levels of performance. While 
the response to the World Health Report 2000 was an indication of the potential 
power of such comparisons, it also highlighted the limitations of health system 
comparisons, such as lack of comparable data and underdeveloped methodologies 
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of comparison (Murray and Evans, 2003). Although the science of comparison is 
advancing rapidly, there still remains great potential for misinterpretation and abuse 
of comparative information. 
 
Yet, International comparisons are without question an important potential driver of 
health system improvement. Measurement is central to securing accountability for 
health system actions and outcomes to citizens, patients and payers (Cylus and 
Smith, 2013; Papanicolas and Smith, 2013; Smith et al., 2010). At the European level 
another major driver behind increased demand for comparisons is the discussion and 
recent approval of the healthcare legislation aimed at making cross-border 
healthcare for European Union (EU) citizens possible (Legido-Quigley et al., 2011).  
 
This focus on assessment coincides with the enormous increase in the capacity for 
measurement and analysis of the last decade, driven in no small part by massive 
changes in information technology and associated advances in measurement 
methodology. Various recent ongoing initiatives and developments have the potential 
to add further value to international comparisons, such as the further development of 
electronic health records and data linkage, which may greatly improve data collection 
and coordination at the system level.  
 
This chapter seeks to summarize the current state of international health system 
comparisons by highlighting the key achievements that have been made in data 
collection and methodological issues as well as outlining the key challenges and 
priorities for future work. In particular, the chapter will consider what performance 
domains are compared, the development of data sources and measurement 
instruments across these domains, and what the analytic methodologies are used to 
assess international evidence on performance. It will conclude by presenting key 
lessons and future priorities that policy-makers should take into account. 
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How to conceptualize a comparison? 
 
A theoretical framework is necessary to assist organizations in defining a set of 
measures that reflect key objectives and in turn allow for an appropriate assessment 
of their performance (Murray and Evans, 2003; Papanicolas, 2013). In their review of 
health system frameworks, Hsiao and Sidat (2008) propose a threefold classification 
of frameworks. The first type of framework they outline is a ‘descriptive framework’. 
This type of framework provides a basic description of the health system and the 
components it is made up of, yet does not explain why any particular health system 
would perform better than another; one example is the European Observatory on 
Health Systems and Policies’ Health Systems in Transition (HiT) country profiles 
which provide detailed descriptions of each European healthcare system including 
reform and policy incentives (http://www.euro.who.int/en/about-
us/partners/observatory/health-systems-in-transition-hit-series). As health systems 
differ considerably with regards to their organization, structure and design, this type 
of framework can be particularly useful in order to understand the various features of 
the health system that may influence differential levels of performance attainment. 
 
The next type of framework is and ‘analytical functional framework’. This type of 
framework goes beyond describing what exists in a health system to also analyzing 
the functional components of a system. This offers a more holistic and deeper 
analysis of health systems than the purely descriptive frameworks, but does not 
reveal the effectiveness of particular policies, reforms or interventions. For example, 
the WHO 2000 health system framework identifies both the health system objectives 
and the functions of the health system which will influence the attainment of these 
goals (Murray and Frenk, 2000).  
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The final type of framework, ‘deterministic frameworks’ differ by attempting to 
determine what factors influence the performance of the health system in order to 
identify which reforms, interventions or policies are most successful. One example of 
this types are called monitoring and evaluation (M&E) frameworks. Monitoring refers 
to the planned and systematic process of observation to compare what is expected 
to what is actually happening. While evaluation is concerned with achieving pre-
defined set criteria. Taken together, M&E necessitates the regular tracking and 
subsequent reporting of relevant information on a health service and its intended 
process, output and outcome. A properly functioning M&E framework should allow 
the policy maker to make better resource allocation decisions, through the rigorous 
and systematic collection of information to determine the value of a given health 
service. 
 
The choice of a useful type of framework depends on the purpose of the 
performance evaluation. For example, at the systems level an M&E framework may 
not be feasible given the number of complex relationships that contribute to the 
attainment of particular objectives. In this case, a descriptive or an analytic 
framework may be more informative, while an M&E framework may still provide 
necessary insight as to whether a particular policy or intervention is producing the 
desired results.  
 
Where are we now?  
 
As outlined by the WHO (2000), international organizations, such as the WHO, the 
OECD, and the EU play an important role in facilitating the comparisons of health 
systems and their own efforts at national performance assessment. These 
organizations produce global norms, standards and guidance. Thus many of the 
international benchmarking exercises undertaken are based on conceptual 
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frameworks constructed and populated using comparative data at produced by, or 
funded by, these organizations. Despite existing differences in key objectives and 
priorities at the national levels, it is possible these international efforts identify the 
broad areas of health system performance that are valued and compared 
internationally (Table 8.1). 
 
Table 8.1 Key performance domains measured internationally 
Performance 
Domain 
What it aims to measure Types of indicators reported 
in comparisons 
Population health The health of the entire population Life expectancy; healthy life 
expectancy; avoidable mortality 
Health service 
outcomes 
The outcomes of different areas of the 
health system (e.g. preventative care, 
primary care, secondary care, long-
term care, mental health) 
Case fatality rates; readmission 
rates; ambulatory care sensitive 
conditions; healthcare 
processes 
Patient experience/ 
responsiveness 
Aspects of patient’s non-clinical 
interaction with their health system; 
populations’ perceptions of how their 
health system meets their 
expectations; the degree to which 
health systems respect people’s 
fundamental basic rights. 
Particular patient experiences; 
patient satisfaction; population 
satisfaction; waiting times; 
patient choice; respect of 
patients dignity; prompt attention 
to medical needs. 
Financial protection The degree to which the health 
system protects citizens from the 
financial consequences of ill health. 
Out-of-pocket spending; 
catastrophic expenditures on 
healthcare; impoverishing 
expenditures on healthcare. 
Equity The distribution of key objectives 
across different groups of the 
population. 
Distribution of health status by 
population/ demographic/ social 
groups; distribution of access/ 
utilization of health services by 
population/ demographic/ social 
groups; progressivity of 
financing system. 
Productivity The amount output produced given 
inputs invested (at different levels 
including the system level and 
organizational levels). 
Average length of stay; unit 
costs. 
Source: authors’ own table 
 
There are often major interpretations as to how the different domains of performance 
are defined, where and if they overlap, how they relate to key health system 
objectives as well as the terminology used to describe them. This exists in particular 
for domains such as patient experience, quality and efficiency. For example, in the 
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area of patient experience – while most stakeholders identify the importance of 
measuring areas that have to do with users non-clinical interaction with their health 
system, in practice both the conceptualization of this area and its measurement differ 
greatly across organizations. Even the name of this area is different, employing 
terms such as ‘satisfaction’ or ‘responsiveness’ and/or ‘patient experience’ which 
refer to distinct but overlapping concepts. 
 
Aside from the conceptual difficulties discussed above another challenge in 
conducting international comparisons is the differential progress made in the 
development of data collection techniques across the different performance 
dimensions. Some areas, such as population health can be quite reliably captured 
through established indicators, while other areas such as efficiency are in earlier 
stages of development.  
 
Quality is often difficult to define as it includes a number of different dimensions. 
While efficiency is difficult to conceptualize because it refers to the degree of 
performance attained relative to what is attainable given resources which 
presupposes a good understanding of all other performance domains. Many 
international frameworks will reconcile these concepts by identifying quality is seen 
as the attainment of high absolute levels in the main objectives, equity as the 
distribution of these goals across the population, and efficiency as the level of overall 
performance relative to what is attainable (Hurst and Jee-Hughes, 2001; Murray and 
Frenk, 2000).  
 
However, given the complicated and multi-faced nature of these dimensions, it 
becomes extremely challenging to identify suitable metrics. As a result, measures 
corresponding to these domains tend be fragmentary metrics. For example, quality is 
often measured by specific health service outcomes or levels of attainment of best-
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practice clinical practices, while efficiency is often captured by unit costs of individual 
services. 
 
Development of metrics in key performance domains 
 
The range and content of available performance data vary considerably between 
countries. International organizations such as the OECD and the WHO attempt to 
report on a range of indicators in each of the domains (Table 8.1), but are also 
constrained by available data in their member states. Countries will focus different 
degrees of effort at collecting new information to fill existing data gaps, as opposed to 
using the information that is readily available or out of date.  
 
Population health 
The ultimate goal of any health system is to improve the health of its population. 
Thus it follows, that some of the most common comparisons of health systems use 
population health data to consider the trends and variations in aggregated health. In 
the past decades major progress has been made in population health indicators, and 
particularly with regards to their ability to capture: (1) variations in morbidity as well 
as mortality; and (2) the contribution of healthcare to health.  
 
The main indicators used to make cross country comparisons in population health 
capture the aggregate mortality experience across populations, such as life 
expectancy infant mortality and age-standardized mortality. One of the great 
advantages of these indicators is the availability of data and ease of calculation 
which permits comparisons across many different countries. However, while these 
trends can summarize the total mortality experience across a given population over a 
particular time period, they do indicate the contribution of healthcare to health status, 
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particularly if there is an absence of data on cost of death (Karanikolos et al., 2013; 
Nolte et al., 2010). 
 
Age standardized mortality rates by cause can more informative about particular 
trends in the burden of illness. Where mortality rates are more sensitive to the quality 
of medical care these indicators are also better able to assess the contribution of the 
health system. For example particular age/disease specific indicators – such as 
neonatal mortality, ischemic heart disease mortality, or HIV mortality are often 
considered better indicators of health system performance. While age-standardized 
mortality rates by cause are easy to calculation and reliable data is available for most 
high and middle income countries, these are indicators are more susceptible to 
recording and reporting practices. For example, in some instances coding of cases 
differs considerably across countries, such as for perinatal mortality, and can account 
for huge apparent differences in mortality. Even where coding is standardized, such 
as through the International Classification of Disease (ICD) system, changes over 
time and variations in interpretation across countries may have effects on apparent 
trends (Fahy, 2013). For example, there may be an apparent shift when a new code 
is introduced, or when a country switches to a new version of a code.  
 
In some cases, data are available on incidence and mortality, such as cancer. In 
these instances it is possible to calculate disease-specific survival – which indicates 
the average length of time that individual survive following diagnosis. While cross-
country comparisons of survival rates can be very influential, and thought to reflect 
variations in quality of care across countries, there are a number of issues that need 
to be taken into account when attempting to draw conclusions from them. The first is 
the sampling of the populations included in the analysis, which may differ across 
countries and/or influenced by the availability data linkage systems across countries; 
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for example countries with better linkage systems may have shorter survival rates as 
more cases are reported at time of death (Coleman et al., 2008).  
 
Interpretations of differences of cross country rates should also be approached with 
caution, given variations in national approaches to diagnosis and treatment. 
Countries with extensive screening activities in place will detect more cases earlier – 
but if this is not attached to significant survival benefit (as for prostate cancer) 
survival rates will seem artificially longer (Karanikolos et al., 2013).  
 
One of the key limitations to the indicators discussed above is that their focus is on 
population mortality rather than population health. The past 20 years have seen 
major efforts in the measurement of morbidity, and summary measures that are able 
to provide more information on the total health experience. It is not uncommon for 
household surveys to measure and report on self-reported health status and disease-
specific measures. Summary measures such as health adjusted life expectancy 
(HALE) and DALYs are able to report on the combined mortality and disability in the 
population. These require measurements on the incidence and relative valuation of 
disability states.  
 
More recent research in the area of population health has focused identifying metrics 
which are able to better measure the contribution of health services to improved 
health. This has led to the development of concepts such as avoidable mortality that 
refers to deaths that are considered avoidable in the presence of appropriate and 
timely medical care or preventable by population-based interventions (Nolte and 
McKee, 2004). This involves reviewing the clinical literature to identify a list of 
conditions that is amenable to healthcare and then measure the deaths occurring in 
these conditions.  
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While this indicator is able to provide more insight into the performance of the health 
system it does suffer from some notable limitations related to measurement and 
interpretation. Its aggregated nature may disguise what is driving the overall figure, 
as well as important variations within countries. Moreover, it does not take into 
account the dynamic nature of the health system – that is the lag that can occur 
between treatment and effect. Finally, this indicator needs constant updating to 
reflect changes in medical practice and technology.  
 
Health service outcomes and processes 
Many international comparisons of health system performance are interested in the 
value added by different health services, or health service outcomes. Currently the 
majority of internationally comparable data in this area is related to mortality 
outcomes in acute care. Yet, given the increasing incidence of mental illness, chronic 
conditions and multiple co-morbidities across the world more emphasis needs to be 
put on the development of a richer set of indicators that are able to capture morbidity 
outcomes as well as performance across different health service settings including 
primary care, long-term care and mental illness (Klazinga and Li, 2013).   
 
Although clinical outcome measures are the gold standard for measuring health 
service outcomes in healthcare, their use can be problematic, for example if the 
outcomes cannot realistically be assessed in a timely or feasible fashion, or when 
trying to understand the contribution of health services to health outcomes. Many 
indicators will thus focusing on mortality rates associated with procedures where the 
quality of care is known to have a large impact on patient outcomes, such as those 
that are heavily dependent on technical skill. Popular outcome indicators of this sort 
are 30-day mortality rates for acute myocardial infarction (AMI) and Stroke.  
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Another way to assess quality directly related to health service performance is 
through process measures. Process measures have certain distinct advantages, for 
example, they are quicker to measure, and easier to attribute directly to health 
service efforts. However, process measures may ultimately ignore the effectiveness 
or appropriateness of the intervention and pre-judge the nature of the response to a 
health problem, which may not be identical in all settings, such as for patients who 
have multiple morbidities. To avoid this they should be measured with appropriate 
exclusion criteria, and to make them more meaningful to patients and policy-makers 
it is best to report them as related to outcomes.  
 
Hospital level readmission rates are also becoming increasingly popular health 
service outcome measures, and many countries are now attaching financial penalties 
to keep them low. A number of studies question whether readmission rates can serve 
as a good indicator of health service performance as readmissions may be the result 
of poor quality care of other parts of the health system (primary care), behavioral 
factors (poor adherence), or even the result of good quality hospital care. A recent 
literature review (Fischer et al., 2012) indicated that routinely collected data on 
readmissions alone is most likely insufficient to draw conclusions about quality given 
inaccurate and incomplete coding of the indicator, and little evidence to indicate that 
readmissions are related with quality of care carried out. 
 
One of the main sources of comparable international indicators in this area is the 
OECD Health Care Quality Indicators (HCQI) project, initiated in 2001, which aims to 
measure and compare the quality of health service provision, across different types 
of heath service settings, in different countries. Another important development in the 
assessment of health service performance has been the growing use of patient 
reported outcome measures. These types of measures typically ask patients to 
assess their current health status, or aspects of health problems (Fitzpatrick, 2010).  
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Patient experience, responsiveness and satisfaction 
System performance measures related to patient and population expectations of 
non-health enhancing aspects of the health system are also increasingly gaining 
interest since a decade or so. Here, a range of non-clinical factors are considered, 
such as service availability, patient choice and how the system respects patient 
dignity, autonomy and confidentiality. One major challenge is the use of different 
concepts, whereas three different terms are most popular: satisfaction, experience 
and responsiveness (Busse, 2013).   
 
Relevant data to measure the performance of health systems in these areas are 
collected by surveys of patients or the general population (Valentine et al., 2010). 
Amongst patients, satisfaction scores typically represent attitudes to care or aspects 
of care, while among the general population, satisfaction metrics capture broader 
attitudes towards the health system. Measures of satisfaction vary considerably in 
two particular respects: the group whose satisfaction is measured, and the type of 
satisfaction.  
 
Metrics in this area are sensitive to a multitude of factors. For instance, systematic 
reviews report that socio-demographic characteristics and health service delivery 
characteristics may impact in reported satisfaction and create bias. Yet the strength 
and direction of the relationships between satisfaction and socio-economic 
categories are not consistent (Bleich et al., 2009; Papanicolas et al., 2013). Similarly, 
studies find that patient satisfaction may not be highly correlated with health 
outcomes or the technical quality of care provided. Rather, patients have been 
influenced by the manner and means of the processes of healthcare delivery, such 
as having a choice of provider or a good patient-practitioner relationship (Crow et al., 
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2006). Survey design issues, such as scaling and wording, are also likely to create 
variations in responses.  
 
In a review of international data on satisfaction, Busse (2013) identifies three factors 
that may influence survey responses: (1) the context in which a survey takes place, 
(2) the ability for respondents to differentiate between the system as a whole and 
certain subsectors about which the respondent may be especially knowledgeable, 
and (3) the inability to differentiate between the healthcare system and government 
in general. These factors may apply across both individuals and countries, and a lack 
of universally accepted terminology may further complicate the development of 
comparable metrics. 
 
Furthermore, expectations concerning health system performance, on which 
individual satisfaction levels are inherently based, are likely to vary across both 
patients and populations. Respondents with lower expectations may report higher 
satisfaction with unsatisfactory care and vice versa. This bias has prompted many 
researchers to explore respondents’ experiences of care in addition to more 
subjective attitudinal questions (Jenkinson et al., 2002). A growing body of 
international metrics of this sort is now available for a subset of countries (such as 
those covered by the Commonwealth Fund and the OECD).   
 
Equity and financial protection 
The principle of equity in health addresses the distribution of performance objectives 
(such as health improvement and responsiveness) across the different groups in the 
population (see also Chapter 33 by Roberts). In practice, international comparisons 
in this area tend to focus separately on what Aday and colleagues (2004) called 
substantive and procedural equity, or the wider study of disparities in health across 
groups, and the study of equity within the healthcare system. For example, the study 
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of the variation in health outcomes across the population would fall within substantive 
equity, while the study in variations of access to healthcare would fall under 
procedural equity.  
 
Various exogenous factors also impact in equity, including socio-economic factors, 
demographic factors and genetics (Hernandez-Quevedo and Papanicolas, 2013). 
Here, international comparisons reveal that inequities in health status related to 
socio-economic factors exist in most countries, but the reasons may be different. 
With regard to procedural equity, different financing mechanisms (such as user fees, 
and co-payments) and organizational structures have been linked to differences in 
access to healthcare services (Hernandez-Quevedo and Papanicolas, 2013).   
 
A number of different tools are used to assess procedural and substantive equity and 
to compare the performance across countries (Table 8.2). Typically, the use of these 
tools requires information on the outcome of interest linked to socio-economic 
variables in order to study the distribution across populations of interest. Large 
improvements in international comparisons of equity, both substantive and 
procedural, can be made through improvements in availability and quality of 
population health and health service outcome data.  
 
Most notably, efforts to link various databases and to provide more detailed 
longitudinal data will allow researchers and policy-makers to better assess, how 
factors within and outside the health system influence equity, whether they persist 
over time, and how they are influenced by policy changes within or outside the 
healthcare system. 
 
Table 8.2 Main indicators used to compare equity and financial protection 
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Main indicators Limitations 
Substantive equity indicators 
Equity in health 
outcomes; 
gap measures, 
correlation and 
regression measures, 
Gini-like coefficients 
(Gini-index for health, 
Concentration index) 
Limited by the availability of outcome indicators and the linkage to 
socioeconomic variables;  
surveys may include outcome and socio-economic information, but 
subjective measures of health status raise methodological problems; 
longitudinal data are lacking;  
objective measures such as physicians’ assessments or hospital 
stays are best for comparative purposes, but availability is limited; 
biomarker may be biased, are not included in longitudinal data, and 
are often not standardized across countries.  
Procedural equity indicators 
Equity in access or 
utilization 
unmet need, use-needs 
ratios, odds ratios, 
horizontal index 
Utilization is not equivalent to access, but terms are often used 
indistinctively, implying that an individual’s use of health services is 
proof that he/she can access these services; 
utilization and need are often captured by survey information, which 
can suffer from reporting bias as well as comparability issues across 
countries;  
little data is collected longitudinally, and there are large gaps on data 
to inform on environmental factors. 
Financial protection indicators 
Catastrophic and 
impoverishing health 
payments; 
out-of-pocket payments 
Limited insights into major determinants of inadequate financial 
protection in a given context;  
do not inform on relationships between financial barriers to access 
and the level of financial protection, and individuals at risk; 
lack of research into complex factors affecting access to health 
services as determinants of financial protection levels does not allow 
for reliable conclusions; 
cross-country examinations of the relative importance of out-of-
pocket expenses for funding the health system can convey helpful 
insights for performance comparisons of financial risk;  
comparing the extent of financial protection requires micro-data 
related to households’ out-of-pocket health expenses to some metric 
in terms of their living standards. 
Source: authors’ own table, adapted from Hernandez-Quevedo and Papanicolas, 2013; 
Moreno-Serra et al., 2013; Papanicolas and Smith, 2013. 
 
Financial protection is often studied separately from equity and looks specifically at 
the extent to which people are protected from the financial consequences of ill-health 
and the use of medical care (Moreno-Serra et al., 2013). Here, useful measurement 
tools have been developed to assist policy-makers, comprising indicators related to 
out-of-pocket payments made to healthcare either as a percent of total expenditures 
or related to some income threshold.  
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Productivity and efficiency 
There are perhaps no performance indicators that receive more attention than the 
related concepts of productivity and efficiency. The notion of health system 
productivity and efficiency is in essence quite simple: they both attempt to measure 
how much valued output (such as health or responsiveness) is produced relative to 
associated inputs, but efficiency also considers this in relation to the maximum output 
that could be produced (Papanicolas and Smith, 2014).  
 
Furthermore, economists often differentiate between two types, namely allocative 
efficiency and technical efficiency. Allocative efficiency indicates the extent to which 
limited funds are directed towards producing the correct mix of healthcare inputs, 
such as health services, in line with the preferences of payers. Technical efficiency 
indicates the extent to which a provider is securing the minimum costs or the 
maximum quantity of outputs, regardless of the value placed on those outputs.  
 
International comparisons of health system efficiency offer great potential for 
stakeholders to compare different system’s value for money and create incentives for 
knowledge exchange and policy-learning. However, conceptual and methodological 
complexities place these useful performance indicators among the most difficult to 
estimate. While health system efficiency is probably the most desirable efficiency 
metric for policy-makers, comparable efficient and productivity metrics can be 
constructed to evaluate any segment of the health production process, including the 
number of surgical procedures per physician (i.e. physical inputs to activities) or the 
additional years of life associated with spending on health (i.e. cost to outcome). 
These metrics are also extremely useful for informing national policy and fostering 
meaningful comparisons within and across country settings.  
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The most desirable measure of efficiency in the health sector is one that captures the 
full production process, from health expenditures to health outcomes (Hollingsworth, 
2003). Satisfactory measurement of whole system efficiency therefore relies on many 
issues in individual performance domains. For this reason, there is a need for a more 
feasible and useful strategy to examine efficiency by scrutinizing the operation of 
specific parts of the health system, or whole system efficiency for the treatment of 
particular cases. An example of the first approach is the measurement and 
comparison of indicators, such as the average ‘length of in-patient stay’ that are 
collected in many settings over a long period.  
 
On national level, cost per quality-adjusted life year (QALY) of an intervention is a 
common indicator to capture the full production process but for an adjusted case. An 
intervention is technically efficient, if it provides a maximum number of QALYs at a 
given level of spending, while a healthcare purchaser would be efficient in allocation 
resources, if they pay for an optimal mix of interventions that maximizes population 
health. The QALY indicator is not without problems. Measures of the full production 
process are often elusive for many areas of the health system, due to the problems 
to observe and quantify health outcomes (Busse et al., 2008; Street et al., 2010).  
 
One response to the problems is the use of statistical or non-parametric tools to 
estimate a production possibilities frontier, and use this to compare the efficiency of 
health systems (Joumard, 2010; WHO, 2000) or health system organizations. Typical 
approaches include stochastic frontier analysis or data envelopment analysis, both of 
which use information on the observed behaviour of all organizations to infer the 
maximum feasible level of attainment (the production function) and to offer estimates 
of the extent to which each individual organization falls short of that optimum. The 
methods take radically different approaches and are technically challenging; 
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consequently, while being conceptually appealing, there are few examples of such 
methods being used by decision-makers.   
 
Conclusion 
 
Individual nations are increasingly introducing more systematic methods for health 
system performance assessment, including benchmarking activities with other 
countries. These developments have significantly improved and fostered cross-
country comparison. There is now wide consensus around the identification of key 
performance domains that should be compared, and the degree of comparability and 
availability of international health data in these areas has also improved. At the same 
time, many challenges persist and call for further investigations in this area.  
 
Comparisons need to be conducted with properly validated measures, metrics must 
be widely accepted and defined in unambiguous terms that are consistent with most 
countries’ data collection systems, and users should be familiar with limitations in 
existing indicators. Table 8.3 presents a collection of commonly used performance 
indicators for major performance domains, what the indicator measures, and the 
assumptions it is making.  
 
Table 8.3 Sample of performance indicators  
Dimension Example 
indicator 
What is it? What are the assumptions and 
what does it ignore? 
Population 
health 
Avoidable mortality 
 
 
Prevalence of 
disease 
Death rate for conditions 
determined to be amenable to 
timely and effective 
healthcare. 
Percentage of a population 
diagnosed with given condition 
Conditions considered to be amenable 
to healthcare are identified by expert 
opinion and may differ across 
countries. 
Individuals who do not visit health 
facilities are not accounted for 
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Health 
services 
outcomes 
30 day acute 
myocardial infarction 
(AMI) mortality rate 
(risk adjusted) 
 
 
28 day hospital 
readmission rates 
Hospital-level risk-
standardized mortality rate 
from any cause within 30 days 
following a primary admission 
due to AMI. 
 
Rate of emergency 
readmission to hospital 
following previous admission 
for specified conditions (e.g. 
AMI) within specified time 
frame 
Reflects differences in hospital care 
while adjusting for individual-level 
factors; but does not adequately reflect 
care received outside the hospital; 
complications arising from hospital 
stay are not generally used for risk-
adjustment. 
Possible sample selection bias, where 
hospitals that have higher survival 
rates may have higher readmission 
rates simply because more of their 
patients survive and have the 
possibility of readmission 
Patient 
experience 
Waiting times for hip 
replacement 
 
 
Satisfaction with 
health system 
The average waiting time for a 
hip replacement operation 
 
 
Self-reported ratings of how 
satisfied individuals are with 
the health system 
Does not account for quality of 
services; possible cross-country 
differences in willingness to wait for 
services vs. willingness to purchase 
private sector services. 
Often includes individuals who have 
not used health services; satisfaction 
scores have been found to be 
unrelated to experiences using health 
services; reporting bias. 
Financial 
Protection 
Catastrophic health 
spending 
 
 
 
Percent of health 
expenditure out-of-
pocket 
Percentage of households with 
healthcare payments at or 
exceeding 40% of a 
household's capacity to pay in 
a given year 
 
Share of total healthcare 
spending paid for out-of-
pocket by households 
Ignores individuals who do not use 
services because they are unable to 
pay. Only out-of-pocket spending is 
accounted for; assumes that there are 
no additional changes to income levels 
associated with ill-health. 
Ignores individuals who do not use 
services because they are unable to 
pay. 
Equity Concentration index 
 
 
 
 
 
Unmet need due to 
cost 
Level of income-related health 
inequality within a population; 
if the measure of health is ill-
health, values < 0 indicate 
greater ill-health among the 
poor, and vice-versa. 
Self-reported question whether 
an individual did not access 
health services due to cost 
Assumes that a value of 0 means no 
socioeconomic-related inequalities 
exist, though this may not be true; 
results are sensitive to different 
measures of living standards. 
 
Self-reporting bias; possible inability of 
individuals to assess own level of 
need; individuals may account for 
various types of costs. 
Efficiency Cost effectiveness 
of certain 
intervention; 
Average length of 
stay 
Cost per QALY 
 
 
The numer of days per 
hospital inpatient stay 
Assumes average costs of providing 
intervention do not change with scale; 
major data constraints. 
Cases are identical, both in terms of 
outcomes and in terms of intensity. 
Source: authors’ own table 
 
In sum, rapid progress in all areas of data collection, including areas such as the 
design, collection, governance, linkage and dissemination of data, allow to create a 
more holistic picture of health determinants and develop more reliable indicators, and 
in turn, to improve comparison. The adoption of IT systems in healthcare 
organizations and the systematization of classifications within and across countries 
(using tools such as diagnostic resource groupings and/or ICD codes) also foster 
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robust comparisons across organizations. Finally, information and communication 
technologies (ICT) – often termed ‘e-health’ – may also help to improve the data 
sources for comparison. 
 
Summary 
 International comparisons allow for within and cross-country learning, and may 
serve as drivers of healthcare system improvement. 
 Comparisons need to be conducted with properly validated measures. 
 Metrics must be widely accepted and defined in unambiguous terms that are 
consistent with most countries’ data collection systems; and users should be 
familiar with limitations in existing indicators.  
 Development of performance indicators for different domains has made 
significant progress and will be furthermore fostered by new technologies, but still 
many challenges and constrains of comparison remain to be solved.  
 
Key reading 
Papanicolas, I. and P. C. Smith (eds.) (2013) Health System Performance 
Comparison: An Agenda for Policy, Information and Research (Maidenhead: 
Open University Press). 
Smith, P. C., E. Mossialos, I. Papanicolas and S. Leatherman (eds.) (2010) 
Performance Measurement for Health System Improvement: Experiences, 
Challenges and Prospects (Cambridge: Cambridge University Press). 
 
References 
 
Aday, L. A., C. E. Begley, D. R. Lairson and R. Balkrishnan (2004) Evaluating the 
Healthcare System: Effectiveness, Efficiency, and Equity (Chicago: Health 
Administration Press). 
21 
 
Bleich, S. N., E. Ozaltin and C. J. L. Murray (2009) ‘How Does Satisfaction with the 
Health-care System Relate to Patient Experience?’, Bulletin of the World Health 
Organization, 87, 271–8. 
Busse, R. (2013) ‘Understanding Satisfaction, Responsiveness and Experience with 
the Health System’, in I. Papanicolas and P. C. Smith (eds.), Health System 
Performance Comparison: An Agenda for Policy, Information and Research 
(Maidenhead: Open University Press), 255–80. 
Busse, R., J. Schreyögg and P. Smith (2008) ‘Variability in Health Care Treatment 
Costs amongst Nine EU countries – Results from the Health BASKET Project’, 
Health Economics, 17, S1–S8. 
Coleman, M. P., M. Quaresma, F. Berrino, J. M. Lutz and R. De Angelis (2008) 
‘Cancer Survival in Five Continents: A Worldwide Population-based Study 
(CONCORD)’, The Lancet Oncology, 9 (8), 730–56. 
Crow, R., H. Gage, S. Hampson, J. Hart, A. Kimber, L. Storey and H. Thomas (2006) 
‘The Measurement of Satisfaction with Healthcare: Implications for Practice from 
a Systematic Review of the Literature’, Health Technology Assessment, 6 (32), 
1–244. 
Cylus, J. and P. C. Smith (2013) ‘Efficiency’, in I. Papanicolas and P. C. Smith (eds.), 
Health System Performance Comparison: An Agenda for Policy, Information and 
Research (Maidenhead: Open University Press), 281–312. 
Fahy, N. (2013) ‘Commentary on International Health System Data’, in I. Papanicolas 
and P. C. Smith (eds.), Health System Performance Comparison: An Agenda for 
Policy, Information and Research (Maidenhead: Open University Press), 313–34. 
Fischer, C., H. A. Anemia and N. Klazinga (2012) ‘The Validity of Indicators for 
Assessing Quality of Care: A Review of the European Literature on Hospital 
Readmission Rate’, European Journal of Public Health, 22 (4), 484–91.  
Fitzpatrick, R. (2010) ‘Patient-reported Outcome Measures and Performance 
Measurement’, in P. C. Smith, E. Mossialos, I. Papanicolas and S. Leatherman 
22 
 
(eds.), Performance Measurement for Health System Improvement: Experiences, 
Challenges and Prospects (Cambridge: Cambridge University Press), 63–87.  
Hernandez-Quevedo, C. and I. Papanicolas (2013) ‘Conceptualizing and Comparing 
Equity across Nations’, in I. Papanicolas and P. C. Smith (eds.), Health System 
Performance Comparison: An Agenda for Policy, Information and Research 
(Maidenhead: Open University Press), 183–223. 
Hollingsworth, B. (2003) ‘Non-parametric and Parametric Applications Measuring 
Efficiency in Health Care’, Health Care Management Science, 6 (4), 203–18. 
Hsiao, W. H. and B. Sidat (2008) ‘Health Systems: Concepts and Deterministic 
Models of Performance’, Background Paper Prepared for the Workshop on 
Research Agendas on Global Health Systems, Harvard University, 3–5 
December 2008.   
Hurst, J. and M. Jee-Hughes (2001) ‘Performance Measurement and Performance 
Management in OECD Health Systems’, OECD Labour Market and Social Policy 
Occasional Papers, no. 47 (Paris: OECD). 
Jenkinson, C., A. Coulter and S. Bruster (2002) ‘The Picker Patient Experience 
Questionnaire: Development and Validation Using Data from In-patient Surveys 
in Five Countries’, International Journal for Quality in Health Care, 14, 353–8. 
Joumard, I., C. André and C. Nicq (2010) ‘Health Care Systems: Efficiency and 
Institutions’, OECD Economics Department Working Papers, No. 769 (Paris: 
OECD). 
Karanikolos, M., B. Khoshaba, E. Nolte and M. McKee (2013) ‘Population Health’, in 
I. Papanicolas and P. C. Smith (eds.), Health System Performance Comparison: 
An Agenda for Policy, Information and Research (Maidenhead: Open University 
Press), 127–57. 
Klazinga, N. and L. Li (2013) ‘Health Service Outcomes’, in I. Papanicolas and P. C. 
Smith (eds.), Health System Performance Comparison: An Agenda for Policy, 
Information and Research (Maidenhead: Open University Press), 157–81. 
23 
 
Legido-Quigley, H., I. Passarani, C. Knai, R. Busse, W. Palm, M. Wismar and M. 
McKee (2011) ‘Cross-border Healthcare in the European Union: Clarifying 
Patients Rights’, British Medical Journal, 342: d296.  
Moreno-Serra, R., S. Thompson and K. Xu (2013) ‘Financial Protection’, in I. 
Papanicolas and P. C. Smith (eds.), Health System Performance Comparison: 
An Agenda for Policy, Information and Research (Maidenhead: Open University 
Press), 223–54. 
Murray, C. J. L. and J. Frenk (2000) ‘A Framework for Assessing the Performance of 
Health Systems’, Bulletin of the World Health Organization, 78, 717–30. 
Murray, C. J. L. and D. Evans (2003) ‘Health Systems Performance Assessment: 
Goals, Framework and Overview’, in C. L. J. Murray and D. Evans (eds.), Health 
Systems Performance Assessment: Debates, Methods and Empiricism (Geneva: 
World Health Organization), 3–23. 
Nolte, E., C. Bain and M. McKee (2010) ‘Population Health’, in P. C. Smith, E. 
Mossialos, I. Papanicolas and S. Leatherman (eds.), Performance Measurement 
for Health System Improvement: Experiences, Challenges and Prospects 
(Cambridge: Cambridge University Press), 27–63. 
Nolte, E. and M. McKee (2004) Does Healthcare Save Lives? Avoidable Mortality 
Revisited (London: Nuffield Trust). 
Nolte, E., S. Wait and M. McKee (2006) Investing in Health: Benchmarking Health 
Systems (London: Nuffield Trust). 
Papanicolas, I. (2013) ‘Frameworks for International Comparison’, in I. Papanicolas 
and P. C. Smith (eds.), Health System Performance Comparison: An Agenda for 
Policy, Information and Research (Maidenhead: Open University Press), 31–74. 
Papanicolas, I., J. Cylus and P. C. Smith (2013) ‘An Analysis of Survey Data from 
Eleven Countries Finds that “Satisfaction” with Health System Performance 
Means Many Things’, Health Affairs, 32 (4), 734–42. 
24 
 
Papanicolas, I. and P. C. Smith (eds.) (2013) Health System Performance 
Comparison: An Agenda for Policy, Information and Research (Maidenhead: 
Open University Press). 
Papanicolas, I. and P. C. Smith (2014) ‘The Theory of Systems Level Efficiency in 
Health Care’, in T. Culyer, A. Tsuchiya and J. Wildman (eds.), The Elsevier On-
line Encyclopaedia of Health Economics, Vol. 3 (Elsevier), 386–94.  
Smith, P. C., E. Mossialos, I. Papanicolas and S. Leatherman (eds.) (2010) 
Performance Measurement for Health System Improvement: Experiences, 
Challenges and Prospects (Cambridge: Cambridge University Press). 
Street, A. and U. Hakinnen (2010) ‘Measuring Productivity’, in P. C. Smith, E. 
Mossialos, I. Papanicolas and S. Leatherman (eds.), Performance Measurement 
for Health System Improvement: Experiences, Challenges and Prospects 
(Cambridge: Cambridge University Press), 222–49. 
Valentine, N. B., A. Prassad, N. Rice, S. Robone and S. Chatterji (2010) ‘Health 
Systems Responsiveness: A Measure of the Acceptability of Health Care 
Processes and Systems from the User’s Perspective’, in P. C. Smith, E. 
Mossialos, I. Papanicolas and S. Leatherman (eds.), Performance Measurement 
for Health System Improvement: Experiences, Challenges and Prospects 
(Cambridge: Cambridge University Press), 138–86. 
WHO – World Health Organization (2000) World Health Report 2000. Health 
Systems: Improving Performance (Geneva: World Health Organization). 
